Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

Panelists discuss how, cemiplimab, a PD-1 inhibitor, has shown promise as a second-line therapy for advanced NSCLC after progression on prior treatments. Continuing cemiplimab post-progression can ...

A panelist discusses how type 1 diabetes (T1D) is frequently misdiagnosed in adults due to its overlapping clinical features with type 2 diabetes (T2D), resulting in inappropriate treatment strategies ...

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

Oncologists should ask in advance about what young patients and their parents want to be told about changing prognoses, a new ...

New research shows that Medicaid expansion was linked to a 2.1% increase in timely lung cancer surgeries and a 2.8% rise in ...

Medicaid is the main healthcare coverage for people living with HIV in the United States, according to data compiled by KFF.

A trial found magnetic resonance imaging correlated with physical function tests in patients with Duchenne muscular dystrophy ...

The difference between specialty drugs and traditional drugs and how each have vied for market competition, according to Jeff ...

With policymakers considering work requirements for Medicaid eligibility, Jennifer Haley, principal research associate in the ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A phase 1b showed promising results in lowering LDL in patients with heterozygous familial hypercholesterolemia and/or ...